Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer-Reference-Cited by-同舟云学术

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

Published:2015-07-28 Issue:29 Volume:6 Page:26746-26756
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Hyun-Soo¹,Yoon Gun²,Ryu Ji-Yoon³,Cho Young-Jae³,Choi Jung-Joo³,Lee Yoo-Young³,Kim Tae-Joong³,Choi Chel-Hun³,Song Sang Yong⁴,Kim Byoung-Gie³,Bae Duk-Soo³,Lee Jeong-Won³⁵

Affiliation:

1. Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

2. Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan-si, Gyeongsangnam-do, Republic of Korea

3. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

4. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

5. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma;Anticancer Research;2023-08-30

2. SLC5A3 is important for cervical cancer cell growth;International Journal of Biological Sciences;2023

3. The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma;Emergency Medicine International;2022-09-21

4. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization;Cancers;2022-06-16

5. High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma;Anticancer Research;2022-04-30